AJU-A51

· AJU Pharm Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AJU-A51, covering 2024-03-26 to 2024-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients [Phase 3]